Pklrem1Appsc
Endonuclease-mediated Allele Detail
|
Symbol: |
Pklrem1Appsc |
Name: |
pyruvate kinase liver and red blood cell; endonuclease-mediated mutation 1, Applied StemCell |
MGI ID: |
MGI:7572604 |
Synonyms: |
Pklr-, Pklr KO |
Gene: |
Pklr Location: Chr3:89043449-89054091 bp, + strand Genetic Position: Chr3, 39.01 cM
|
Alliance: |
Pklrem1Appsc page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Modified isoform(s), Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: A single nucleotide (G) was deleted from alternative exon 1 (from MetGlu codons ATGGAA) using sgRNAs (targeting ACAGCAGGTACGCAGCAGTATGG and CAGGTACGCAGCAGTATGGAAGG) and an ssODN template with CRISPR/Cas9 technology. This knockout mutation only affects the transcript encoding the shorter liver-specific L-isozyme, which uses an alternative 1st exon downstream from the longer R-isozyme encoding transcript's exon 1.
(J:342736)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Pklr Mutation: |
25 strains or lines available
|
|
Original: |
J:342736 Zhang C, et al., Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning. EBioMedicine. 2022 Aug 18;83:104214 |
All: |
1 reference(s) |
|